600161 天坛生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.0679.53814.78111.92310.458
总资产报酬率 ROA (%)0.7576.72310.3088.1867.189
投入资产回报率 ROIC (%)1.0359.23814.19211.1659.613

边际利润分析
销售毛利率 (%)34.59143.85254.70050.76249.076
营业利润率 (%)19.56629.78842.40534.84233.607
息税前利润/营业总收入 (%)19.58429.51841.68433.76332.109
净利润/营业总收入 (%)15.68624.15535.01829.13828.270

收益指标分析
经营活动净收益/利润总额(%)86.221101.63598.70397.33694.969
价值变动净收益/利润总额(%)2.4731.4802.5102.0691.972
营业外收支净额/利润总额(%)-0.077-0.800-0.415-0.356-0.410

偿债能力分析
流动比率 (X)8.8187.9956.8935.9156.282
速动比率 (X)4.4394.1083.4393.6924.267
资产负债率 (%)7.0677.6398.42110.10512.171
带息债务/全部投入资本 (%)0.7951.4291.0483.6615.967
股东权益/带息债务 (%)12,237.4856,761.7909,261.1632,590.5861,547.292
股东权益/负债合计 (%)1,006.622926.385833.533685.127558.916
利息保障倍数 (X)604.031-883.420-76.390-35.317-23.595

营运能力分析
应收账款周转天数 (天)107.58046.3806.5911.7771.820
存货周转天数 (天)492.301410.141442.258365.297371.289